A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Fan, Hong ^a   Liu, Dongsheng ^a,b   Qiu, Xuemei ^a   Qiao, Fengchang ^a   Wu, Qingxiang ^a   Su, Xianwei ^a   Zhang, Feng ^a   Song, Yunwei ^a   Zhao, Zhujiang ^a   Xie, Wei ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Suqian People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3A; LUCIFERASE; DNA (CYTOSINE 5) METHYLTRANSFERASE;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ESOPHAGUS CARCINOMA; FEMALE; FUNCTIONAL GENOMICS; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; CASE CONTROL STUDY; DNA SEQUENCE; ENZYMOLOGY; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; STOMACH TUMOR;

CASE-CONTROL STUDIES; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; ESOPHAGEAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS;

EID: 77649110590     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-12     Document Type: Article

References (39)

1. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000, 9:2395-2402. 10.1093/hmg/9.16.2395, 11005794.
2. Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998, 19:219-220. 10.1038/890, 9662389.
3. Leonhardt H, Page AW, Weier HU, Bestor TH. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 1992, 71:865-873. 10.1016/0092-8674(92)90561-P, 1423634.
4. Liu Y, Oakeley EJ, Sun L, Jost JP. Multiple domains are involved in the targeting of the mouse DNA methyltransferase to the DNA replication foci. Nucleic Acids Res 1998, 26:1038-1045. 10.1093/nar/26.4.1038, 147368, 9461465.
5. Bird AP, Wolffe AP. Methylation-induced repression--belts, braces, and chromatin. Cell 1999, 99:451-454. 10.1016/S0092-8674(00)81532-9, 10589672.
6. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001, 293:1089-1093. 10.1126/science.1063443, 11498579.
7. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002, 3:662-673. 10.1038/nrg887, 12209141.
8. Lee EJ, Lee BB, Han J, Cho EY, Shim YM, Park J, Kim DH. CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma. Int J Cancer 2008, 123:2073-2079. 10.1002/ijc.23598, 18697202.
9. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003, 52:502-506. 10.1136/gut.52.4.502, 1773595, 12631658.
10. Samuel MS, Suzuki H, Buchert M, Putoczki TL, Tebbutt NC, Lundgren-May T, Christou A, Inglese M, Toyota M, Heath JK, Ward RL, Waring PM, Ernst M. Elevated Dnmt3a activity promotes polyposis in Apc Min mice by relaxing extracellular restraints on Wnt signaling. Gastroenterology 2009, 137:902-13. 10.1053/j.gastro.2009.05.042, 19454286.
11. Shikauchi Y, Saiura A, Kubo T, Niwa Y, Yamamoto J, Murase Y, Yoshikawa H. SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma. Mol Cell Biol 2009, 29:1944-1958. 10.1128/MCB.00840-08, 2655625, 19139273.
12. Lorente A, Mueller W, Urdangarín E, Lázcoz P, Lass U, von Deimling A, Castresana JS. RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs. Brain Pathol 2009, 19:279-292. 10.1111/j.1750-3639.2008.00185.x, 18616639.
13. Bachman KE, Rountree MR, Baylin SB. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 2001, 276:32282-32287. 10.1074/jbc.M104661200, 11427539.
14. Fuks F, Burgers WA, Godin N, Kasai M, Kouzarides T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J 2001, 20:2536-2544. 10.1093/emboj/20.10.2536, 125250, 11350943.
15. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999, 27:2291-2298. 10.1093/nar/27.11.2291, 148793, 10325416.
16. Benbrahim-Tallaa L, Waterland RA, Dill AL, Webber MM, Waalkes MP. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect 2007, 115:1454-1459. 2022656, 17938735.
17. Ding WJ, Fang JY, Chen XY, Peng YS. The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig Dis Sci 2008, 53:2083-2089. 10.1007/s10620-007-0145-2, 18253830.
18. Hu J, Fan H, Liu D, Zhang S, Zhang F, Xu H. DNMT3B promoter polymorphism and risk of gastric cancer. Dig Dis Sci 2009,
19. Aung PP, Matsumura S, Kuraoka K, Kunimitsu K, Yoshida K, Matsusaki K, Nakayama H, Yasui W. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol Rep 2005, 14:1151-1154.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215. 10.1093/nar/16.3.1215, 334765, 3344216.
21. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell 2004, 5:121-125. 10.1016/S1535-6108(04)00033-9, 14998488.
22. Lee EJ, Lee BB, Han J, Cho EY, Shim YM, Park J, Kim DH. CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma. Int J Cancer 2008, 123:2073-2079. 10.1002/ijc.23598, 18697202.
23. Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, Li H, Cheng YY, Röcken C, Ebert MP, Chan AT, Sung JJ. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 2008, 48:508-518. 10.1002/hep.22343, 18666234.
24. Peng DF, Razvi M, Chen H, Washington K, Roessner A, Schneider-Stock R, El-Rifai W. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut 2009, 58:5-15. 10.1136/gut.2007.146290, 18664505.
25. Park HL, Kim MS, Yamashita K, Westra W, Carvalho AL, Lee J, Jiang WW, Baek JH, Liu J, Osada M, Moon CS, Califano JA, Mori M, Sidransky D. DCC promoter hypermethylation in esophageal squamous cell carcinoma. Int J Cancer 2008, 122:2498-2502. 10.1002/ijc.23434, 18302152.
26. Kim MS, Yamashita K, Chae YK, Tokumaru Y, Chang X, Zahurak M, Osada M, Park HL, Chuang A, Califano JA, Sidransky D. A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma. Clin Cancer Res 2007, 13:6658-6665. 10.1158/1078-0432.CCR-07-1178, 18006766.
27. Fan H, Liu DS, Zhang SH, Hu JB, Zhang F, Zhao ZJ. DNMT3B 579 G>T promoter polymorphism and risk of esophagus carcinoma in Chinese. World J Gastroenterol 2008, 14:2230-2234. 10.3748/wjg.14.2230, 2703851, 18407600.
28. Samuel MS, Suzuki H, Buchert M, Putoczki TL, Tebbutt NC, Lundgren-May T, Christou A, Inglese M, Toyota M, Heath JK, Ward RL, Waring PM, Ernst M. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling. Gastroenterology 2009, 137:902-913. 10.1053/j.gastro.2009.05.042, 19454286.
29. Bachman KE, Rountree MR, Baylin SB. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 2001, 276:32282-32287. 10.1074/jbc.M104661200, 11427539.
30. Deng T, Kuang Y, Wang L, Li J, Wang Z, Fei J. An essential role for DNA methyltransferase 3a in melanoma tumorigenesis. Biochem Biophys Res Commun 2009, 387:611-616. 10.1016/j.bbrc.2009.07.093, 19632198.
31. Dong CX, Deng DJ, Pan KF, Zhang L, Zhang Y, Zhou J, You WC. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study. Int J Cancer 2009, 124:434-439. 10.1002/ijc.23891, 18821580.
32. Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, Hamilton J, Kan T, Krasna MJ, Beer DG, Pepe MS, Abraham JM, Feng Z, Schmiegel W, Greenwald BD, Meltzer SJ. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 2005, 24:4138-4148.
33. Lee EJ, Lee BB, Han J, Cho EY, Shim YM, Park J, Kim DH. CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma. Int J Cancer 2008, 123:2073-2079. 10.1002/ijc.23598, 18697202.
34. Gu P, Xing X, Tänzer M, Röcken C, Weichert W, Ivanauskas A, Pross M, Peitz U, Malfertheiner P, Schmid RM, Ebert MP. Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. Neoplasia 2008, 10:563-572. 2386541, 18516293.
35. Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 2007, 26:934-944. 10.1038/sj.onc.1209839, 16862168.
36. Kim TY, Jong HS, Song SH. DimtchTranscriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene 2003, 22:3943-3951. 10.1038/sj.onc.1206573, 12813468.
37. Long C, Yin B, Lu Q, Zhou X, Hu J, Yang Y, Yu F, Yuan Y. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma. Cancer Invest 2007, 25:685-690. 10.1080/07357900701561131, 18058463.
38. Lee SH, Kim J, Kim WH, Lee YM. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 2009, 28:184-194. 10.1038/onc.2008.377, 18850007.
39. Watanabe Y, Kim HS, Castoro RJ, Chung W, Estecio MR, Kondo K, Guo Y, Ahmed SS, Toyota M, Itoh F, Suk KT, Cho MY, Shen L, Jelinek J, Issa JP. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology 2009, 136:2149-2158. 10.1053/j.gastro.2009.02.085, 19375421.